Carotid artery disease is a condition characterized by the narrowing or blockage of the carotid arteries, the major blood vessels that supply oxygenated blood to the brain. This narrowing is typically caused by the buildup of fatty deposits, known as plaque, on the inner walls of the arteries. As the disease progresses, it can impede blood flow to the brain, increasing the risk of stroke. Carotid artery disease often develops gradually and may not exhibit noticeable symptoms until a significant blockage occurs. Common risk factors include age, smoking, high blood pressure, and elevated cholesterol levels. Diagnosis often involves imaging tests such as ultrasound, CT scans, or magnetic resonance angiography. Treatment options range from lifestyle modifications and medications to surgical interventions like carotid endarterectomy or angioplasty with stent placement. Timely detection and management of carotid artery disease are crucial in preventing potentially severe consequences such as stroke and cognitive impairment. Individuals with risk factors should maintain regular medical check-ups to monitor and address any signs of this vascular condition.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India